...
首页> 外文期刊>BMC Pediatrics >Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis
【24h】

Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis

机译:伊朗新生儿的苯丙酮尿​​筛选:系统审查和荟萃分析

获取原文

摘要

BACKGROUND:Phenylketonuria (PKU), which is characterized by a deficiency of phenylalanine hydroxylase activity, is an autosomal recessive disorder of phenylalanine (Phe) metabolism. Newborn screening is the main population-based public health screening program that allows successful identification and treatment of PKU with low-Phe diet. The aim of this study was to evaluate the epidemiology of PKU screening in Iranian newborns.METHODS:The present study was designed based on MOOSE protocol and reporting was done in accordance with the PRISMA guidelines. The protocol of this systematic review was published in PROSPERO before it was performed (CRD42020162626). A comprehensive search was done in 10/10/2019 to find related literature on international online databases Web of Science, Scopus, EMBASE, Science Direct, PubMed/Medline, EBSCO, CINAHL, Cochrane Library, national online databases and the Google Scholar search engine. Heterogeneity among studies was assessed by Isup2/sup index and Q test. All meta-analyses were performed using Comprehensive Meta-Analysis Software ver. 2. P??0.05 was considered significant.RESULT:Finally, 18 studies with 3,339,327 Iranian neonates were included. The prevalence of suspected hyperphenylalaninemia (HPA) was estimated to be 45.6/100,000 (95% CI: 23.9-87.1). The prevalence of suspected HPA in girls and boys infants in Iran was estimated to be 38.0/100,000 (95% CI:?15.1-95.5) and 43.3/100,000 (95% CI: 16.2-116.2), respectively. The prevalence of PKU was estimated to be 16.5/100,000 (95% CI: 12.9-21.2). The prevalence of PKU in girls and boys infants was estimated to be 13.3/100,000 (95% CI: 7.5-15.8) and 10.9/100,000 (95% CI: 7.5-15.8), respectively. The prevalence of mild to moderate HPA was estimated 9.7/100,000 (95% CI: 5.1-18.4) and the prevalence of classical PKU was estimated 4.4/100,000 (95% CI: 2.5-7.8). Sensitivity analysis for all meta-analysis with the omission of one study showed that overall estimation is still robust.CONCLUSION:The results of this meta-analysis showed that PKU is prevalent in Iranian neonates. It should be considered that for PKU there is a highly effective dietary treatment which can prevent the clinical symptoms of PKU if initiated early after detection by newborn screening.
机译:背景:苯丙酮尿(PKU),其特征在于苯丙氨酸羟化酶活性的缺乏,是苯丙氨酸(PHE)代谢的常染色体隐性疾病。新生儿筛查是基于主要的人口的公共卫生筛查计划,允许使用低phe饮食成功识别和治疗pku。本研究的目的是评估伊朗新生儿中PKU筛查的流行病学。方法:本研究是根据穆索协议设计的,并根据PRISMA准则进行报告。该系统审查的协议在执行之前在Prospero发表(CRD42020162626)。全面搜索是在10/10/2019完成的,在科学,Scopus,Embase,Science,Cinahl,Cochrane图书馆,国家在线数据库和Google学者搜索引擎中查找关于国际在线数据库网络上的相关文献。通过I 2 指数和q测试评估研究中的异质性。使用全面的Meta-Analysis Software Ver进行所有Meta分析。 2. P?<?0.05被认为是显着的。结果:最后,包括3339,327名伊朗新生儿的18项研究。疑似海藻喹啉血症(HPA)的患病率估计为45.6 / 100,000(95%CI:23.9-87.1)。伊朗女孩和男孩婴儿涉嫌HPA的患病率估计为38.0 / 100,000(95%CI:?15.1-95.5)和43.3 / 100,000(95%CI:16.2-116.2)。 PKU的患病率估计为16.5 / 100,000(95%CI:12.9-21.2)。女孩和男孩婴儿的PKU普遍率估计为13.3 / 100,000(95%CI:7.5-15.8)和10.9 / 100,000(95%CI:7.5-15.8)。 MILD到中度HPA的患病率估计为9.7 / 100,000(95%CI:5.1-18.4),估计4.4 / 100,000(95%CI:2.5-7.8)。遗漏一项研究的所有Meta分析的敏感性分析表明,整体估计仍然是稳健的。结论:这种元分析的结果表明,PKU在伊朗新生儿中普遍存在。应该认为对于PKU有一种高效的饮食治疗,可以防止PKU的临床症状,如果通过新生儿筛选检测早期发起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号